In this Issue

Dollar sales in the snack/granola bar category have grown nearly 8% in the past year, according to Sue Viamari, editor of Symphony­IRI Group’s Times and Trends report.


“Growth is being driven by strong performance by nutrition/intrinsic health value bars and granola bars, which climbed 15.6% and 7% during that time period,” she said. Breakfast/cereal bars posted flat sales for the year.


Consumers may have a bit more to spend for the 2011 back-to-school season, so retailers should tweak their merchandise plans to accommodate.


Perry James, an analyst at the NPD Group, said that over the past few years, dollar trends in school supplies have not kept pace with unit supplies. Consumers also have been waiting until the last minute to shop. “As the economy gets better, retailers should be careful about too many promotions late in the season,” James said.

Welmedix’s First Degree therapeutic burn cream provides a unique solution for minor burns that the company suggests is an unmet need at retail. It’s an all-in-one burn cream that helps soothe pain, cool the burn, prevent infection and reduce the appearance of scars.


WASHINGTON — The National Association of Chain Drug Stores and its members from across the country once again are flocking to Capitol Hill for RxImpact Day, a groundbreaking, two-day event that enables pharmacists to meet with members of Congress to discuss the vital role of retail pharmacy within the U.S. healthcare system and its ability to help reduce annual healthcare costs.

WOONSOCKET, R.I. — The next chapter for CVS Caremark officially is under way. The company last month officially named Larry Merlo CEO, effective March 1. Tom Ryan will remain nonexecutive chairman until his retirement in May. Prior to the news, Merlo had been president and COO.

Pharmacy and health policy advocates endlessly tout the cost-saving 
benefits of improved medication adherence. In January, CVS Caremark put more teeth into that argument with some dramatic new findings that should get the attention of every health plan payer.


Just when you thought the low end of the generic drug price spectrum couldn’t get any more commoditized, the $2 price point debuted with a big splash in September 2010.


Walgreens generated quite 
the fanfare in January when it announced free blood-pressure screenings across its pharmacies and Take Care Clinics on the “Oprah Winfrey Show.”